Iranian Journal of Psychiatry and Behavioral Sciences

Published by: Kowsar

Cognitive-Behavioral Therapy for Opiate Users in Methadone Treatment: A Multicenter Randomized Controlled Trial

Mahmood Amini-Lari 1 , * , Zahra Alammehrjerdi 2 , Fatemeh Ameli 1 , Hassan Joulaei 3 , Reza Daneshmand 4 , Hossain Faramarzi 5 , Hamid-Reza Bakhtiyari 1 and Roya Samadi 6
Authors Information
1 Shiraz HIV/AIDS Research Center, Health Institute, Shiraz University of Medical Sciences, Shiraz, IR Iran
2 Iranian National Center for Addiction Studies, Tehran University of Medical Sciences, Tehran, IR Iran
3 Health Policy Research Center, Shiraz University of Medical Sciences, Shiraz, IR Iran
4 Substance Abuse and Dependence Research Center, University of Social Welfare and Rehabilitation Sciences, Tehran, IR Iran
5 Larestan University of Medical Sciences, Larestan, Fars, IR Iran
6 Psychiatry and Behavioral Sciences Research Center, Department of Psychiatry, Mashhad University of Medical Sciences, Mashhad, IR Iran
Article information
  • Iranian Journal of Psychiatry and Behavioral Sciences: June 2017, 11 (2); e9302
  • Published Online: March 4, 2017
  • Article Type: Original Article
  • Received: October 9, 2016
  • Revised: January 22, 2017
  • Accepted: February 24, 2017
  • DOI: 10.5812/ijpbs.9302

To Cite: Amini-Lari M, Alammehrjerdi Z, Ameli F, Joulaei H, Daneshmand R, et al. Cognitive-Behavioral Therapy for Opiate Users in Methadone Treatment: A Multicenter Randomized Controlled Trial, Iran J Psychiatry Behav Sci. 2017 ; 11(2):e9302. doi: 10.5812/ijpbs.9302.

Abstract
Copyright © 2017, Iranian Journal of Psychiatry and Behavioral Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Materials and Methods
4. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. Saberi Zafarghandi MB, Jadidi M, Khalili N. Iran's Activities on Prevention, Treatment and Harm Reduction of Drug Abuse. Int J High Risk Behav Addict. 2015; 4(4)[DOI][PubMed]
  • 2. Shekarchizadeh H, Ekhtiari H, Khami MR, Virtanen JI. Patterns of pre-treatment drug abuse, drug treatment history and characteristics of addicts in methadone maintenance treatment in Iran. Harm Reduct J. 2012; 9: 18[DOI][PubMed]
  • 3. Kheradmand A, Amini Ranjbar Z, Zeynali Z, Sabahy AR, Nakhaee N. Sleep Quality and Sexual Function in Patients Under Methadone Maintenance Treatment. Int J High Risk Behav Addict. 2015; 4(4)[DOI][PubMed]
  • 4. Sheikh Fathollahi M, Torkashvand F, Najmeddin H, Rezaeian M. Predictors of One-Year Retention in Methadone Maintenance Treatment (MMT) in Iran, Rafsanjan. Int J High Risk Behav Addict. 2016; 5(3)[DOI][PubMed]
  • 5. Pashaei T, Moeeni M, Roshanaei Moghdam B, Heydari H, Turner NE, Razaghi EM. Predictors of treatment retention in a major methadone maintenance treatment program in iran: a survival analysis. J Res Health Sci. 2014; 14(4): 291-5[PubMed]
  • 6. Babaie E, Razeghi N. Comparing the effects of methadone maintenance treatment, therapeutic community, and residential rehabilitation on quality of life and mental health of drug addicts. Addict Health. 2013; 5(1-2): 16-20[PubMed]
  • 7. Seyedfatemi N, Peyrovi H, Jalali A. Relapse experience in Iranian opiate users: a qualitative study. Int J Community Based Nurs Midwifery. 2014; 2(2): 85-93[PubMed]
  • 8. Amin-Esmaeili M, Rahimi-Movaghar A, Sharifi V, Hajebi A, Radgoodarzi R, Mojtabai R, et al. Epidemiology of illicit drug use disorders in Iran: prevalence, correlates, comorbidity and service utilization results from the Iranian Mental Health Survey. Addiction. 2016; 111(10): 1836-47[DOI][PubMed]
  • 9. Feeney GF, Connor JP, Young RM, Tucker J, McPherson A. Improvement in measures of psychological distress amongst amphetamine misusers treated with brief cognitive-behavioural therapy (CBT). Addict Behav. 2006; 31(10): 1833-43[DOI][PubMed]
  • 10. Carroll KM, Nich C, Petry NM, Eagan DA, Shi JM, Ball SA. A randomized factorial trial of disulfiram and contingency management to enhance cognitive behavioral therapy for cocaine dependence. Drug Alcohol Depend. 2016; 160: 135-42[DOI][PubMed]
  • 11. Reback CJ, Shoptaw S. Development of an evidence-based, gay-specific cognitive behavioral therapy intervention for methamphetamine-abusing gay and bisexual men. Addict Behav. 2014; 39(8): 1286-91[DOI][PubMed]
  • 12. Jaffe A, Shoptaw S, Stein J, Reback CJ, Rotheram-Fuller E. Depression ratings, reported sexual risk behaviors, and methamphetamine use: latent growth curve models of positive change among gay and bisexual men in an outpatient treatment program. Exp Clin Psychopharmacol. 2007; 15(3): 301-7[DOI][PubMed]
  • 13. American Psychiatric Association. . Diagnostic and Statistical Manual of Mental Disorders: DSM-IV-TR R-. 2000;
  • 14. Azizi A, Borjali A, Golzari M. The effectiveness of emotion regulation training and cognitive therapy on the emotional and addictional problems of substance abusers. Iran J Psychiatry. 2010; 5(2): 60-5[PubMed]
  • 15. Biener L, Abrams DB. The Contemplation Ladder: validation of a measure of readiness to consider smoking cessation. Health Psychol. 1991; 10(5): 360-5[DOI][PubMed]
  • 16. Gossop M, Darke S, Griffiths P, Hando J, Powis B, Hall W, et al. The Severity of Dependence Scale (SDS): psychometric properties of the SDS in English and Australian samples of heroin, cocaine and amphetamine users. Addiction. 1995; 90(5): 607-14[DOI][PubMed]
  • 17. Baker A, Lee NK, Claire M, Lewin TJ, Grant T, Pohlman S, et al. Brief cognitive behavioural interventions for regular amphetamine users: a step in the right direction. Addiction. 2005; 100(3): 367-78[DOI][PubMed]
  • 18. Suvanchot KS, Somrongthong R, Phukhao D. Efficacy of group motivational interviewing plus brief cognitive behavior therapy for relapse in amphetamine users with co-occurring psychological problems at Southern Psychiatric Hospital in Thailand. J Med Assoc Thai. 2012; 95(8): 1075-80[PubMed]
  • 19. Tait RJ, McKetin R, Kay-Lambkin F, Carron-Arthur B, Bennett A, Bennett K, et al. A Web-Based Intervention for Users of Amphetamine-Type Stimulants: 3-Month Outcomes of a Randomized Controlled Trial. JMIR Ment Health. 2014; 1(1)[DOI][PubMed]
  • 20. Nuijten M, Blanken P, van den Brink W, Hendriks V. Treatment of crack-cocaine dependence with topiramate: a randomized controlled feasibility trial in The Netherlands. Drug Alcohol Depend. 2014; 138: 177-84[DOI][PubMed]
  • 21. Jiang H, Du J, Wu F, Wang Z, Fan S, Li Z, et al. Efficacy of contingency management in improving retention and compliance to methadone maintenance treatment: a random controlled study. Shanghai Arch Psychiatry. 2012; 24(1): 11-9[DOI][PubMed]
  • 22. Mokri A, Chawarski MC, Taherinakhost H, Schottenfeld RS. Medical treatments for opioid use disorder in Iran: a randomized, double-blind placebo-controlled comparison of buprenorphine/naloxone and naltrexone maintenance treatment. Addiction. 2016; 111(5): 874-82[DOI][PubMed]
  • 23. Hoseiny H, Jadidi M, Habiballah Nataj L, Saberi-Zafarghandi MB. The effect of methadone-maintenance therapy with and without interactive treatment on improving emotion-regulation strategies and resilience among opiate-dependent clients. Int J High Risk Behav Addict. 2015; 4(1)[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments